InvestorsHub Logo

temp luvs amy

09/21/10 2:54 PM

#517 RE: ash111 #516

Not likely, unfortunately. A broker could consolidate the shares, but it isn't worth it. You can get quoted by the pinks with much simpler paperwork, like form D. This one was only valuable until the SEC deregistered it, and it wasn't worth much.

I will probably eventually take the Form D route instead of considering shells again.

I got the patent, but I haven't had any bidders on that either. I am still working on the production models, but I have had some successes. If they keep the board open, I should be able to update that.

temp luvs amy

01/29/11 1:52 AM

#518 RE: ash111 #516

To make a bad story even worse, my last production model recently failed, and I am recovering with a new version.

On the brighter side, I was contacted by another large holder. A few more, and we could get a quorom.

temp luvs amy

02/14/11 1:29 PM

#519 RE: ash111 #516

I got your private message, and couldn't return it..

I don't pay for membership..

Anyway, I am making some modifications to the system. It just isn't continuing to follow the original successes, and I probably have to tweak the micronutrients or duplicate the original environment. Unfortunately I am not funded to have a team of scientists. It is just me in my garage, so things are moving very, very slowly. The only attention my patent is getting comes from advisors who want me to pay them for their marketing savvy.

I am having some difficulty with people who wish for me to "open source" the data instead of signing non-disclosure pacts. Yeah, I want to give the info away so I can stay broke for the rest of my life. My secret dies with me.

temp luvs amy

02/17/11 12:20 PM

#520 RE: ash111 #516

Results appear to be improving. As I suspected, a nutrient addition seems to have resolved the failure. It could take a few months to confirm, verify, and resume full production. Then I plan on getting loans based on revenues to increase the business model footprint and work on expanding the product line.